These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3860872)

  • 1. Molecular characterization of novel H-2 class I molecules expressed by a C3H UV-induced fibrosarcoma.
    McMillan M; Lewis KD; Rovner DM
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5485-9. PubMed ID: 3860872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and function of three novel MHC class I antigens derived from a C3H ultraviolet-induced fibrosarcoma.
    Linsk R; Vogel J; Stauss H; Forman J; Goodenow RS
    J Exp Med; 1986 Sep; 164(3):794-813. PubMed ID: 3489061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of the MHC genes encoding the tumour-specific class I antigens expressed on a murine fibrosarcoma.
    Stauss HJ; Linsk R; Fischer A; Watts S; Banasiak D; Haberman A; Clark I; Forman J; McMillan M; Schreiber H
    J Immunogenet; 1986; 13(2-3):101-11. PubMed ID: 2880914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of H-2 class I molecules expressed on the UV-induced tumour 1591.
    McKinney DM; McMillan M
    J Immunogenet; 1990 Jun; 17(3):177-87. PubMed ID: 2266273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological characteristics of immunogenic variants induced in the MCA-F murine fibrosarcoma using 1-methyl-3-nitro-1-nitrosoguanidine, 5-aza-2'-deoxycytidine, or ultraviolet radiation.
    Simcik W; Frost P; LeGrue SJ
    Cancer Res; 1989 Aug; 49(15):4192-8. PubMed ID: 2472875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor-rejection antigens of the 1591 ultraviolet fibrosarcoma. Potential origin and evolutionary implications.
    Linsk R; Watts S; Fischer A; Goodenow RS
    J Exp Med; 1989 Mar; 169(3):1043-58. PubMed ID: 2564413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-idiotypic antibodies against UV-induced tumor-specific CTL clones. Preparation in syngeneic combination.
    Kuribayashi K; Tanaka C; Matsubayashi Y; Masuda T; Udono H; Abe M; Nakayama E; Shiku H
    J Immunol; 1988 Dec; 141(11):4074-80. PubMed ID: 2460558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
    Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
    Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
    Roberts LK
    J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential extraction of tumor-specific antigens from two ultraviolet light-induced murine fibrosarcomas with the use of 1-butanol.
    Simcik WJ; Kripke ML; Sheu TL; LeGrue SJ
    Cancer Res; 1988 Dec; 48(24 Pt 1):7004-8. PubMed ID: 3142680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of tumor-associated antigens on ultraviolet light-induced tumors using antitumor antibodies developed in ascites fluid.
    Fortner GW; Takemoto LJ; Shehi L; Hansen JS
    Cancer Res; 1982 Jun; 42(6):2371-4. PubMed ID: 7042083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble factors produced during an immune response regulate Ia antigen expression by murine adenocarcinoma and fibrosarcoma cells.
    Callahan GN
    J Immunol; 1984 May; 132(5):2649-57. PubMed ID: 6201554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
    Chen PW; Kaba DS; Ananthaswamy HN
    Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel MHC class I molecule as a tumour-specific antigen. Correlation between the antibody-defined and the CTL-defined target structure.
    Philipps C; Stauss HJ; Wortzel RD; Schreiber H
    J Immunogenet; 1986; 13(2-3):93-9. PubMed ID: 3493299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to NK and metastatic potential of fibrosarcoma cells is associated with products encoded by the H-2D region.
    Rager-Zisman B; Aboud M; Gopas J; Har-Vardi I; Hämmerling GJ; Segal S
    Semin Cancer Biol; 1991 Oct; 2(5):329-36. PubMed ID: 1773048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of monoclonal antibodies with MHC class I antigens on mouse spleen cells. II. Levels of expression of H-2K, H-2D, and H-2L in different mouse strains.
    Dower SK; Segal DM
    J Immunol; 1985 Jan; 134(1):431-5. PubMed ID: 2578048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble factors from murine and human tumors induce suppressor cells.
    Jessup JM; Kahan BD; LeGrue SJ; Rutzky L; Pellis NR
    J Surg Res; 1984 Jun; 36(6):631-8. PubMed ID: 6539407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
    Alon Y; Hammerling GJ; Segal S; Bar-Eli M
    Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical analysis of a novel H-2 class I-like glycoprotein expressed in five AKR-(Gross virus) derived spontaneous T cell leukemias.
    Labeta MO; Fernandez N; Reyes A; Ferrara P; Marelli O; Le Roy E; Houlihan J; Festenstein H
    J Immunol; 1989 Aug; 143(4):1245-53. PubMed ID: 2473124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW; Kripke ML
    J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.